• MJHLS Brand Logo

© 2022 MJH Life Sciences™ , NeurologyLive – Clinical Neurology News and Neurology Expert Insights. All rights reserved.

Jenna Payesko

Ophthal

Articles

FDA Rejects Duchenne Muscular Dystrophy Drug Golodirsen, Citing Safety Concerns

August 23, 2019

Article

The regulatory agency cited 2 concerns in the complete response letter: the risk of infections related to intravenous infusion ports and renal toxicity.

FDA Rejects Duchenne Muscular Dystrophy Drug Golodirsen, Citing Safety Concerns

August 20, 2019

Article

The regulatory agency cited 2 concerns in the complete response letter: the risk of infections related to intravenous infusion ports and renal toxicity.

Pfizer Recalls Relpax for Migraine Due to Potential Microbiological Contamination

August 20, 2019

Article

Those with an existing inventory of eletriptan hydrobromide 40 mg tablets, lots AR5407 and CD4565, should stop use and distribution, and quarantine immediately.

Phase 3 Trial of Vutrisiran Evaluates Potential Therapy for Hereditary Transthyretin-Mediated Amyloidosis

August 19, 2019

Article

The investigational candidate is the subject of a phase 3 study assessing efficacy and safety in adults with hATTR amyloidosis with transthyretin mutation.

The Symbiotic Relationship of Artificial Intelligence and Neurology

August 18, 2019

Article

The associate chief of the MS division and professor of neurology at the University of Pennsylvania described the relationship between artificial intelligence and medicine, and how he sees it evolving in the future.

Jeffrey Cummings, MD, ScD, on Investigational Therapies for Alzheimer Disease

August 14, 2019

Article

The director emeritus of the Cleveland Clinic Lou Ruvo Center for Brain Health and vice chair of the department of brain health at the University of Nevada Las Vegas spoke about cognitive enhancing agents, disease-modifying therapies, and neuropsychiatric therapies under investigation for Alzheimer disease.

Exploring the Impact of Caregiver Depression on Patients With Dementia

August 12, 2019

Article

The neurohospitalist and assistant professor of neurology at the University of California San Francisco spoke about how caregiver depression is an important risk factor associated with increased healthcare use among individuals with dementia.

Diazepam Buccal Film Beneficial in Refractory Epilepsy With Seizure Clusters

August 12, 2019

Article

The new drug application for Libervant is expected to be completed in the fourth quarter of 2019, which if approved, would offer a potentially first in class oral treatment for breakthrough or cluster seizures.

Diazepam Buccal Film Beneficial in Refractory Epilepsy With Seizure Clusters

August 08, 2019

Article

The new drug application for Libervant is expected to be completed in the fourth quarter of 2019, which if approved, would offer a potentially first in class oral treatment for breakthrough or cluster seizures.

Young Blood Plasma Beneficial in Parkinson Disease

August 07, 2019

Article

Six-month results show significant improvements in motor symptoms, mentation, behavior, and mood, with a prolonged residual benefit.